FR2373543A1 - Derives de pyrimido/1,2-a/benzimidazole destines aux traitements prophylactiques et therapeutiques - Google Patents

Derives de pyrimido/1,2-a/benzimidazole destines aux traitements prophylactiques et therapeutiques

Info

Publication number
FR2373543A1
FR2373543A1 FR7737011A FR7737011A FR2373543A1 FR 2373543 A1 FR2373543 A1 FR 2373543A1 FR 7737011 A FR7737011 A FR 7737011A FR 7737011 A FR7737011 A FR 7737011A FR 2373543 A1 FR2373543 A1 FR 2373543A1
Authority
FR
France
Prior art keywords
prophylactic
therapeutic treatments
pyrimido
benzimidazole derivatives
benzimidazole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7737011A
Other languages
English (en)
Other versions
FR2373543B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB51426/76A external-priority patent/GB1585965A/en
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Publication of FR2373543A1 publication Critical patent/FR2373543A1/fr
Application granted granted Critical
Publication of FR2373543B1 publication Critical patent/FR2373543B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

L'invention concerne l'industrie pharmaceutique. Elle a pour objet des pyrimidoØ1,2-aõbenzimidazoles dont certains peuvent exister sous une ou plusieurs formes tautomères et isomères, de même qu'un procédé pour les préparer par réaction d'un benzimidazole de départ avec un acide éthylénique ou bien par cyclisation d'un autre benzimidazole convenablement substitué. Ces composés ont la propriété d'inhiber l'agrégation des thrombocytes et sont dès lors préférés pour les traitements prophylactiques et thérapeutiques nécessitant une telle application.
FR7737011A 1976-12-09 1977-12-08 Derives de pyrimido/1,2-a/benzimidazole destines aux traitements prophylactiques et therapeutiques Granted FR2373543A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB51426/76A GB1585965A (en) 1976-12-09 1976-12-09 3,4-dihydropyrimido (1,2 - )benzimidazol - 2(1h) - ones
GB3334177 1977-08-09

Publications (2)

Publication Number Publication Date
FR2373543A1 true FR2373543A1 (fr) 1978-07-07
FR2373543B1 FR2373543B1 (fr) 1980-05-16

Family

ID=26261828

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7737011A Granted FR2373543A1 (fr) 1976-12-09 1977-12-08 Derives de pyrimido/1,2-a/benzimidazole destines aux traitements prophylactiques et therapeutiques

Country Status (23)

Country Link
US (1) US4167569A (fr)
JP (1) JPS5390296A (fr)
AT (1) AT359068B (fr)
AU (1) AU514427B2 (fr)
CA (1) CA1086727A (fr)
CH (1) CH633291A5 (fr)
CS (1) CS199696B2 (fr)
DD (1) DD133330A5 (fr)
DE (1) DE2754930A1 (fr)
ES (1) ES464862A1 (fr)
FI (1) FI63577C (fr)
FR (1) FR2373543A1 (fr)
GR (1) GR65298B (fr)
HU (1) HU176540B (fr)
IE (1) IE45924B1 (fr)
IL (1) IL53507A (fr)
IT (1) IT1143729B (fr)
NL (1) NL7713658A (fr)
NO (1) NO774216L (fr)
NZ (1) NZ185823A (fr)
PL (1) PL107142B1 (fr)
SE (1) SE435385B (fr)
SU (1) SU843751A3 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1157858A (fr) 1979-12-03 1983-11-29 Ikuo Ueda Derives de quinazoline
IE51802B1 (en) * 1979-12-03 1987-04-01 Fujisawa Pharmaceutical Co Quinazoline derivatives,processes for their preparation and pharmaceutical compositions containing them
DE3208218A1 (de) * 1982-03-06 1983-09-08 Basf Ag, 6700 Ludwigshafen Isoindolinfarbstoffe und deren verwendung
RU2394824C1 (ru) * 2008-12-25 2010-07-20 Государственное научное учреждение Северо-Кавказский зональный научно-исследовательский ветеринарный институт Российской академии сельскохозяйственных наук ПРОИЗВОДНЫЕ ПИРИДО [1,2-a]БЕНЗИМИДАЗОЛА, ОБЛАДАЮЩИЕ АНТИБАКТЕРИАЛЬНЫМ ДЕЙСТВИЕМ, И СПОСОБ ИХ ПОЛУЧЕНИЯ
BR112014032581A8 (pt) 2012-06-27 2018-08-14 4Sc Discovery Gmbh inibidores de bifluorodioxalano-amino-benzimidazol quinase para o tratamento de câncer, distúrbios do snc e inflamação autoimune

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3468888A (en) * 1967-04-11 1969-09-23 Smithkline Corp 2-substituted pyrimido(1,2-a) benzimidazoles

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3988340A (en) * 1975-01-23 1976-10-26 Bristol-Myers Company 6-Alkoxymethyl-1,2,3,5-tetrahydroimidazo[2,1-b]quinazolin-2-ones and 7-alkoxymethyl-6-[H]-1,2,3,4-tetrahydropyrimido[2,1-b]quinazolin-2-ones
US4072679A (en) * 1976-06-15 1978-02-07 E. R. Squibb & Sons, Inc. 1,4- AND 4,10-DIHYDRO-4-OXO-PYRIMIDO (1,2-A)-benzimidazole-3-carboxylic acids, esters and amides

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3468888A (en) * 1967-04-11 1969-09-23 Smithkline Corp 2-substituted pyrimido(1,2-a) benzimidazoles

Also Published As

Publication number Publication date
JPS5390296A (en) 1978-08-08
IE45924L (en) 1978-06-09
US4167569A (en) 1979-09-11
FI773724A7 (fi) 1978-06-10
NL7713658A (nl) 1978-06-13
IE45924B1 (en) 1982-12-29
PL107142B1 (pl) 1980-01-31
IT1143729B (it) 1986-10-22
SE435385B (sv) 1984-09-24
CS199696B2 (en) 1980-07-31
HU176540B (en) 1981-03-28
FR2373543B1 (fr) 1980-05-16
SE7713958L (sv) 1978-06-10
IL53507A0 (en) 1978-03-10
AU514427B2 (en) 1981-02-12
SU843751A3 (ru) 1981-06-30
ATA883677A (de) 1980-03-15
IL53507A (en) 1981-07-31
NZ185823A (en) 1980-08-26
DD133330A5 (de) 1978-12-27
FI63577C (fi) 1983-07-11
AU3112177A (en) 1979-06-07
CA1086727A (fr) 1980-09-30
AT359068B (de) 1980-10-27
ES464862A1 (es) 1979-01-01
NO774216L (no) 1978-06-12
FI63577B (fi) 1983-03-31
DE2754930A1 (de) 1978-06-15
CH633291A5 (de) 1982-11-30
GR65298B (en) 1980-08-01
PL202753A1 (pl) 1978-10-09

Similar Documents

Publication Publication Date Title
IL123002A0 (en) 1-Phenyl-2- phenylacetoxy- ethanone derivatives
NO308601B1 (no) Tricykliske benzazepiner og farmasøytisk preparat inneholdende disse
ES2114882T3 (es) Acidos hidroxialquilquinolinos insaturados como antagonistas de leucotrienos.
TR199901174T2 (xx) Yeni heterosiklilmetil-ikameli pirazol t�revleri.
BR9401484A (pt) Hidrazida de ácido 1h-indol-3-acético e formulação farmacêutica
PT94377A (pt) Processo de preparacao de acidos imidazolilalcenoicos e de composicoes farmaceuticas que os contem
EA199900853A1 (ru) Замещенные производные бензопирана для лечения воспалительных процессов
ES2162942T3 (es) Nuevos derivados de acidos carboxilicos, su obtencion y empleo.
DE122006000010I1 (de) Benzocyclobutyl- oder Indanyl-Alkyl-Amino-Alkyl substituierte 3- Benzazepin-2-ones, verwendbar in der Behandlung von kardiovaskularen Krankheiten
RU94042393A (ru) Галихондрины, родственные соединения и способ лечения опухоли у млекопитающих
PL318282A1 (en) Benzoyl derivatives and method of obtaining them
ATE128985T1 (de) Hydantoinderivate.
MX168918B (es) Proceso para preparar compuestos de quinolona
ES2133714T3 (es) Compuestos heterociclicos para el tratamiento de trastornos del snc y cardiovasculares.
NO944946L (no) Forgrenet-amino-substituerte tiazoler, fremgangsmåter for fremstilling av dem og farmasöytiske blandinger inneholdende dem
ES2083396T3 (es) Acidos fenilalcan(en)oicos.
ES2151168T3 (es) N-(2,4-dioxo-2,3,4,5-tetrahidro-1h-1,5-benzodiazepin-3-il)-3-amidas.
MX9203751A (es) Compuestos de arilo disubstituido que exhiben actividad antagonista selectiva de leucotrieno b4.
NO891703L (no) Farmasoeytiske sammensetninger for behandling av psoriasis.
ES2194102T3 (es) Nuevas n-(2,4-dioxo-2,3,4,5-tetrahidro-1h-1,5-benzodiazepin-3-il)-3-amidas.
NO905254D0 (no) Fremgangsmaate for fremstilling av substituerte cykloheksener.
EA199700243A1 (ru) Производное аминотетралина для лечения сердечно-сосудистых заболеваний
NO171912C (no) Fremgangsmaate for fremstilling av 5-klor-3-klorsulfonyl-2-tiofenkarboksylsyreestere
DK229984A (da) 4-oxothiazolidin-2-yliden-acetamidderivater
ES2058196T3 (es) Derivados de azacromano.

Legal Events

Date Code Title Description
ST Notification of lapse